Literature DB >> 11148726

Encrustation of biomaterials in the urinary tract.

M Sofer1, J D Denstedt.   

Abstract

The present review focuses on technological advances and relevant research related to encrustation of biomaterials in the urinary tract. The importance of physical and chemical biomaterial type, biocompatibility, material coatings such as hydrogels, and infection related to alloplastic materials used in urological practice are discussed. Recent in-vitro and in-vivo research has focused on materials that will reduce encrustation and bacterial biofilm formation, complications that limit the long-term use of urinary materials. Coordinating scientific resources in a multidisciplinary manner for a better understanding of factors that are involved in encrustation and biofilm formation will offer the potential to modify or resolve the problem of encrustation of foreign materials in the urinary tract.

Mesh:

Substances:

Year:  2000        PMID: 11148726     DOI: 10.1097/00042307-200011000-00005

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  4 in total

Review 1.  Encrustation of biomaterials in the urinary tract.

Authors:  Greg L Shaw; Simon K Choong; Christopher Fry
Journal:  Urol Res       Date:  2004-12-22

Review 2.  The role of biofilm infection in urology.

Authors:  P Tenke; B Kovacs; M Jäckel; E Nagy
Journal:  World J Urol       Date:  2006-01-10       Impact factor: 4.226

3.  Evaluation of a novel gel-based ureteral stent with biofilm-resistant characteristics.

Authors:  Brian M Rosman; Joao A B A Barbosa; Carlo P Passerotti; Marc Cendron; Hiep T Nguyen
Journal:  Int Urol Nephrol       Date:  2013-12-24       Impact factor: 2.370

4.  Nanoscale surface modification favors benign biofilm formation and impedes adherence by pathogens.

Authors:  Barbara W Trautner; Analette I Lopez; Amit Kumar; Danish M Siddiq; Kershena S Liao; Yan Li; David J Tweardy; Chengzhi Cai
Journal:  Nanomedicine       Date:  2011-12-23       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.